期刊文献+

脂蛋白脂酶降解与代谢异常性疾病 被引量:7

Lipoprotein lipase degradation and metabolic disorders
下载PDF
导出
摘要 脂蛋白脂酶(LPL)的蛋白降解是调节机体LPL水平的重要途径之一,新近研究发现LPL降解受到多种相关蛋白的调控,LPL的降解过程主要包括细胞内降解和细胞外降解两部分。LPL的细胞内降解主要是相关蛋白调控新生的LPL转移到溶酶体中降解;LPL的细胞外降解包括细胞外成熟的LPL和循环中的LPL降解两个过程,主要是LPL被重新摄取或转运至细胞内,随内体聚集到溶酶体降解。因此,本文针对不同时期的LPL降解及其调控进行归纳整理,并阐述LPL降解与代谢异常性疾病之间的关系。 Lipoprotein lipase (LPL) degradation is one of the important ways to regulate the level of LPL. Recently, it has been found that LPL degradation is regulated by a variety of related proteins, the process of LPL degradation mainly includes two parts:intracellular degradation and extracellular degradation. The intracellular degradation of LPL means a large amount of newborn LPL which were transferred to the lysosome for degradation via the related proteins. The extracellular degradation of LPL means mature LPL which were re-uptaked or transported into the cell under the action of the related proteins, and then gathered into lysosomal for degradation. This article will review the LPL in the process of LPL protein synthesis, transportation and biological functions, and then elucidate the relationship between its degradation and metabolic syndrome.
出处 《中国动脉硬化杂志》 CAS 北大核心 2017年第5期513-518,共6页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金项目(81270269 81370377 81570408) 南华大学分子靶标新药研究协同创新中心研究生创新性实验项目(0223-0002-D0033)
关键词 脂蛋白脂酶 溶酶体降解 动脉粥样硬化 糖尿病心肌病 肥胖 Lipoprotein lipase Lysosomes degradation Atherosclerosis Diabetic cardiomyopathy Obesity
  • 相关文献

参考文献2

二级参考文献59

  • 1Davies BS, Beigneux AP, Fong LG, et al. New wrinkles in lipoprotein lipase biology. Curt Opin Lipidol, 2012, 23 : 35 - 42.
  • 2Klinger SC, Glerup S, Raarup MK, et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sei, 2011, 124 : 1095- 1105.
  • 3Gareia-Areos I, Hiyama Y, Drosatos K, et al. Adipose-spe- cific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J Biol Chem, 2013, 288 : 14046 - 14058.
  • 4Westermann D, Walther T, Savvatis K, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation andfibrosis during the development of experimental diabetic car- diomyopathy. Diabetes, 2009, 58 : 1373 - 1381.
  • 5He C, Zhu H, Li H, et al. Dissociation of Bcl-2-Beclinl complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabe- tes, 2013,62 : 1270 - 1281.
  • 6Kumar S, Kain V, Sitasawad SL. High glucose-induced Ca2- overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and inde- pendent pathways. Biochim Biophys Acta, 2012, 1820 : 907 - 920.
  • 7Noh HL, Yamashita H, Goldberg IJ. Cardiac metabolism and mechanics are altered by genetic loss of lipoprotein tri- glyceride lipolysis. Cardiovasc Drugs Ther, 2006, 20 : 441 - 444.
  • 8Haddley K. Alipogene tiparvovec for the treatment of lipo- protein lipase deficiency. Drugs Today (Bare), 2013, 49 : 161 - 170.
  • 9Wang Y, Puthanveetil P, Wang F, et al. Severity of diabe- tes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes, 2011,60 : 2041 2050.
  • 10Chen W, Chen W, Xia Y, et al. Therapy with Astragalus polysaecharides rescues lipotoxic eardiomyopathy in MHC- PPARalpha mice. Mol Biol Rep, 2013, 40 : 2449 -2459.

共引文献11

同被引文献69

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部